SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Generation Income Properties completed the disposition of a Starbucks-occupied net lease retail property located in Tampa, Florida, selling the asset for $2,964,000 with net proceeds of $1,959,170. The transaction was entered into pursuant to a Material Definitive Agreement (Purchase and Sale Agreement) and represents a material reduction in the company's real estate portfolio.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder meeting results held on May 21, 2026. The filing reports voting outcomes on four proposals: election of four directors (all approved), ratification of Deloitte as independent auditors (approved), advisory vote on NEO compensation (approved), and a proposal to declassify the Board (not approved). The detailed vote tallies and outcomes are the core substance of the disclosure, making this unambiguously a shareholder_vote_results event that is material to investors assessing governance and board composition.
View raw filing on EDGAR →Carl Albert, the Chairman of the Board, notified the Company on May 18, 2026 of his decision not to seek re-election at the July 24, 2026 Annual Meeting, meaning he will depart from his director and Chairman roles. While the disclosure also mentions his transition to Chairman Emeritus with an advisory agreement and equity compensation, the principal disclosed action is the departure of a sitting Chairman and director. The filing emphasizes that his decision is not due to disagreement and that he will continue serving until the Annual Meeting, but the core event is his departure from the Board.
View raw filing on EDGAR →This 8-K Item 8.01 discloses a material amendment to the Company's proxy statement regarding an extension of the business combination deadline from 18 months to 27 months from IPO, contingent on sponsor funding of up to $60,000 per monthly extension. While this is a shareholder vote matter, it does not fit neatly into "shareholder_vote_results" (which reports outcomes of votes already held) but rather announces a material modification to terms being submitted for shareholder approval at the June 18, 2026 Extraordinary General Meeting. The extension materially affects the timeline and economics of the SPAC's business combination obligation and redemption rights, making it material to investors.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Taylor Morrison's 2026 Annual Meeting of stockholders held on May 21, 2026, including voting outcomes for four proposals: election of eight directors, advisory approval of named executive officer compensation ("say-on-pay"), frequency of future say-on-pay votes, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core content, making this a textbook shareholder vote results disclosure under Item 5.07.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder voting results from BlackRock's 2026 Annual Meeting of Shareholders held on May 20, 2026. The filing presents detailed voting tallies for four matters: election of 19 directors, advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and amendment to BlackRock Finance, Inc.'s certificate of incorporation. All matters passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and shareholder sentiment.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Fiserv's annual shareholder meeting held on May 21, 2026. The filing presents voting results for four matters: election of eleven directors, advisory vote on named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and a shareholder proposal on independent board chair policy. The detailed vote tallies (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of shareholder vote result disclosures and are material to investors assessing corporate governance and shareholder sentiment.
View raw filing on EDGAR →Akamai completed a $3.5 billion convertible note offering ($1.75 billion 2030 Notes and $1.75 billion 2032 Notes) in a private placement under Rule 144A and Section 4(a)(2), with conversion rates of 4.9650 and 5.2408 shares per $1,000 principal respectively, creating significant dilution potential for existing shareholders. The offering also included warrant transactions with additional dilutive effects if stock price exceeds strike prices.
View raw filing on EDGAR →Akamai used approximately $350 million of net proceeds from the convertible notes offering to repurchase 2.48 million shares of common stock at $141.34 per share in privately negotiated transactions, representing a material capital allocation decision concurrent with the debt offering.
View raw filing on EDGAR →Michele Ann Colucci was appointed to the Board of Directors on May 18, 2026, as a Designated Director by the Class B Majority Shareholder, expanding the board from seven to eight members.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from CCC's May 21, 2026 annual meeting of stockholders, covering four proposals: election of three Class II directors, advisory frequency vote on executive compensation, advisory say-on-pay vote, and ratification of Deloitte as independent auditor. The filing presents detailed vote tallies for each proposal and confirms the outcomes, which is the core purpose of Item 5.07 disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from CBRE's annual meeting held on May 21, 2026, including election of 10 directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and rejection of a stockholder proposal regarding special meetings. Item 5.07 is the designated Item for shareholder vote results, and the filing presents detailed vote tallies for each proposal.
View raw filing on EDGAR →Three board members—Stephen Brady, Michael Raab, and Christine Pellizzari—resigned from the Board of Directors effective May 22, 2026. The filing explicitly states these resignations were not due to disagreement with the Company. The simultaneous departure of three directors is a material event affecting board composition and governance, and would affect a reasonable investor's assessment of the registrant's leadership and stability.
View raw filing on EDGAR →The disclosure concerns an unsolicited tender offer from Zodiac Partners II, which constitutes M&A activity material to investors. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01 or 2.01, the substance is a potential change of control transaction that would significantly affect the registrant's strategic direction and shareholder value.
View raw filing on EDGAR →The filing discloses that Mission Produce and Calavo obtained antitrust clearance from Mexico's COFECE for the previously announced acquisition of Calavo by Mission Produce, with expected consummation on May 28, 2026. This represents a material milestone in the completion of a merger transaction—the removal of a significant regulatory condition to closing. The disclosure of the joint press release announcing regulatory approval and the imminent closing date constitutes a reportable M&A activity event under Item 1.01 or 2.01.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Welltower's 2026 Annual Meeting of Shareholders held on May 21, 2026, including voting outcomes on three proposals: election of nine directors, ratification of Ernst & Young LLP as auditor, and an advisory vote on named executive officer compensation. The filing explicitly states that the compensation proposal "was not approved," which is material to investors as it signals shareholder dissatisfaction with executive pay arrangements. The detailed vote tallies for each director and proposal are the core content of this 8-K section.
View raw filing on EDGAR →SiTime completed a $1.35 billion registered public offering of 0% Convertible Senior Notes due 2031 with a conversion rate of 0.9611 shares per $1,000 principal amount. The convertible structure creates significant dilution potential to common shareholders upon conversion, and the proceeds are intended to fund the Renesas acquisition.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of MannKind's 2026 Annual Meeting of Stockholders held on May 20, 2026, including tabulated votes on three matters: election of nine directors, advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The disclosure directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →LiveWire Group consummated an Asset Purchase Agreement on May 18, 2026, acquiring substantially all of Dust Motorcycles' assets related to electric motorcycles, dirt bikes, and powertrain technology for total consideration of up to $12.75 million, including cash, stock, installments, and contingent earn-outs.
View raw filing on EDGAR →LiveWire Group held its 2026 Annual Meeting of Stockholders on May 21, 2026, with voting results reported for the election of seven director nominees and ratification of KPMG LLP as independent auditor.
View raw filing on EDGAR →Tempest Therapeutics received a deficiency letter from Nasdaq on May 19, 2026, notifying the company it failed to meet the minimum stockholders' equity requirement of $2.5 million (the company reported only $822,000 as of March 31, 2026). Additionally, on May 22, 2026, the company received notice of non-compliance with multiple Nasdaq board composition rules due to director resignations. The company has 45 days to submit a compliance plan and faces potential delisting if it cannot regain compliance within the extended 180-day cure period. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →All In FutureTech Alliance received a deficiency letter from Nasdaq on May 19, 2026, notifying it of non-compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for Q1 2026 and continued delinquency in filing its 2025 Form 10-K. The letter explicitly identifies these filing failures as bases for potential delisting.
View raw filing on EDGAR →SunPower entered into a note purchase agreement on May 19, 2026 for issuance of 10.00% Convertible Senior Secured Notes due 2029, issued May 20, 2026. The Notes are convertible into Common Stock at an initial conversion price of approximately $1.64 per share (610.3143 shares per $1,000 principal), with a maximum conversion rate of 884.9557 shares per $1,000 principal following certain corporate events. Item 3.02 explicitly discloses unregistered sales of equity securities under Section 4(a)(2) of the Securities Act. This convertible debt issuance represents a dilutive capital raise with significant equity conversion potential.
View raw filing on EDGAR →Smart Powerr Corp. entered into a securities purchase agreement on May 19, 2026, to issue 4,500,000 shares of common stock at $0.45 per share in a registered direct offering, raising approximately $2 million in gross proceeds, with a provision for additional closings of up to 4,500,000 more shares at the Purchasers' option.
View raw filing on EDGAR →Ondas Inc. disclosed unregistered sales of equity securities exempt from registration under Regulation D, representing a material private placement that dilutes existing shareholders and affects the registrant's capital structure.
View raw filing on EDGAR →Functional Brands Inc. entered into a material definitive Asset Purchase Agreement with BullionFX on May 22, 2026, to acquire the Alchemy product and related blockchain-based financial ecosystem assets in exchange for 100,000 shares of Series D Preferred Stock valued at approximately $142.9 million. The transaction is subject to closing conditions, equity financing requirements, and shareholder approval.
View raw filing on EDGAR →Kyle S. Lutnick was appointed Chief Strategy Officer of Newmark Group on May 19, 2026, a newly created executive officer position reporting to the COO. The disclosure emphasizes his role in shaping firmwide strategic and transformation agenda including AI and technology matters, and his appointment to the Executive Committee. This is a material executive appointment of a senior officer to a strategic leadership role.
View raw filing on EDGAR →Evolution Metals & Technologies Corp. disclosed financial results for the three months ended March 31, 2026, furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →The company announced multiple material corporate developments: commencement of Nasdaq trading under ticker 'EMAT,' a $100 million convertible debenture facility with YA II PN, Ltd., and binding purchase orders for thirteen rare earth magnet production machines. These developments reflect significant operational progress, capital raising, and strategic expansion initiatives.
View raw filing on EDGAR →Columbus Acquisition Corp entered into a material definitive agreement (Business Combination Agreement) with WISeSat.Space Corp, involving creation of a $25,000 unsecured promissory note with conversion rights into private units and issuance of equity securities (Conversion Units and Conversion Shares) subject to completion of the proposed business combination.
View raw filing on EDGAR →The filing discloses the permanent appointment of Heather Schmidt as Chief Financial Officer effective May 22, 2026, following her interim appointment on May 11, 2026. While the section also includes compensatory arrangements (base salary of $425,000, target bonus of 75%, RSU and performance-based awards totaling $600,000), the principal disclosed action centers on the appointment of a named executive to a principal officer role. This is material to investors as it addresses leadership continuity in a critical financial position.
View raw filing on EDGAR →Envoy Medical received a Nasdaq staff determination on November 19, 2025, that its Class A Common Stock failed to comply with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Although the company was granted an initial 180-day compliance period (until May 18, 2026) and subsequently a second 180-day period (until November 16, 2026), the filing explicitly discloses the failure to satisfy a continued listing rule and the delisting risk, which is the core substance of Item 3.01. This is material to investors as it directly threatens the company's continued listing on Nasdaq.
View raw filing on EDGAR →LQR House Inc. entered into a Note Purchase Agreement on May 20, 2026, issuing unsecured promissory notes with an aggregate principal amount of up to $60,000,000 to non-U.S. purchasers. The notes may be convertible or involve digital asset funding, creating a material direct financial obligation.
View raw filing on EDGAR →The filing discloses multiple closings of convertible promissory notes and warrants under a Note Purchase Agreement with White Lion Capital. The third closing on May 18, 2026 involved issuance of a $555,556 convertible note and warrants to purchase 888,509 shares of common stock. Combined with prior closings totaling approximately $1.6M in convertible notes and 2.6M+ warrant shares, this represents a material dilutive issuance of equity securities. Item 2.03 addresses the creation of direct financial obligations (the convertible notes), while the warrant issuances constitute dilutive equity instruments.
View raw filing on EDGAR →This disclosure reports completion of an IPO of 15,000,000 units at $10.00 per unit, a concurrent private placement of 2,750,000 warrants, and partial exercise of an over-allotment option, resulting in total trust account proceeds of $157,785,000 as of May 20, 2026. While the IPO itself is a material capital-raising event, the disclosure is structured as a narrative of completed transactions rather than a traditional earnings release or M&A activity, and does not fit cleanly into the earnings_release or ma_activity categories; it is best classified as other_material given its significance to a blank-check acquisition vehicle's capitalization and timeline for business combination.
View raw filing on EDGAR →The filing discloses entry into an equity distribution agreement on May 22, 2026, authorizing the issuance and sale of up to $100 million in common units through Morgan Stanley as sales agent via at-the-market offerings. This is a classic dilutive equity issuance that would materially affect existing unitholders' ownership percentages and is a significant capital-raising event for the registrant.
View raw filing on EDGAR →This disclosure reports the consummation of Patriot Acquisition Corp.'s IPO on May 18, 2026, generating $160 million in gross proceeds from 16 million units, plus a concurrent private placement of 5.2 million warrants and subsequent partial exercise of the over-allotment option adding $15.075 million, resulting in $175.875 million in trust. While the IPO itself is a material capital-raising event, it does not fit cleanly into the earnings_release category (which typically applies to periodic financial results) or dilutive_issuance (which focuses on unregistered equity sales to raise cash in distressed contexts). This is a SPAC formation event—material to investors but best classified as other_material given the specialized nature of blank-check company capitalization.
View raw filing on EDGAR →On May 21, 2026, the Audit Committee determined that the Company's Q1 2026 interim financial statements (filed May 12, 2026) should no longer be relied upon and must be restated due to accounting errors in revenue recognition. The errors resulted in overstatement of revenue and accounts receivable by $529 thousand and overstatement of gross profit by $296 thousand, stemming from inadequate internal controls over customer modified purchase orders.
View raw filing on EDGAR →The disclosure announces that unit holders may elect to separately trade the component securities (Class A ordinary shares, Warrants, and Rights) of the Company's IPO units, commencing May 28, 2026, with new trading symbols assigned to each component. While this is a routine post-IPO administrative event for a SPAC, it is material to investors as it affects the liquidity and trading mechanics of their securities and represents a significant milestone in the Company's capital structure. This does not fit neatly into more specific categories (not an earnings release, executive change, M&A, impairment, or covenant breach), making "other_material" the appropriate classification.
View raw filing on EDGAR →The filing discloses a shareholder letter for Q1 2026 under Item 7.01 (Regulation FD Disclosure). While the letter likely contains financial or operational updates material to investors, the 8-K itself does not specify the content—only that a letter was issued. Without access to Exhibit 99.1, the precise event type cannot be determined; it could relate to earnings, business developments, or other material matters. Classified as other_material given the uncertainty about the letter's specific content, though it is material enough to warrant 8-K disclosure.
View raw filing on EDGAR →Terra Innovatum Global N.V. received a deficiency notice from Nasdaq on May 19, 2026, for failure to comply with Nasdaq Listing Rule 5250(c)(1) due to delinquent filings of its Form 10-Q and Form 10-K. While the notice has no immediate effect on listing, the company has until June 15, 2026, to submit a compliance plan and until October 12, 2026, to regain compliance, creating material delisting risk. This is a classic Item 3.01 disclosure of failure to satisfy continued listing standards.
View raw filing on EDGAR →This disclosure reports the consummation of a SPAC initial public offering on May 18, 2026, generating $150 million in gross proceeds from the sale of 15 million units at $10.00 per unit, plus a concurrent private placement of $5.375 million. While the IPO itself is a material capital-raising event affecting the registrant's financial position and shareholder base, it does not fit cleanly into the standard 8-K taxonomy categories (not an earnings release, M&A activity, or other specifically enumerated event types). The disclosure is material to investors as it documents the company's capitalization and trust account structure, but the event is primarily administrative/transactional in nature rather than a discrete material event like a covenant breach, impairment, or executive change.
View raw filing on EDGAR →Tenon Medical received a written notice from Nasdaq on May 21, 2026, stating it no longer complies with the minimum stockholders' equity requirement of $2,500,000 under Nasdaq Listing Rule 5550(b)(1), having reported only $1,895,000 in stockholders' equity as of March 31, 2026. The company has 45 days to submit a compliance plan or face delisting, with no assurance of success. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →Faraday Future held its annual meeting of stockholders on May 22, 2026, and disclosed the final voting results for nine proposals including director elections, equity issuances, stock incentive plan amendments, charter amendments for authorized shares and reverse stock split authority, and say-on-pay votes, as certified by the inspector of elections.
View raw filing on EDGAR →La Rosa Holdings received a notice from Nasdaq on May 21, 2026, that the Company does not comply with Nasdaq Listing Rule 5250(c)(1) due to delinquent filings of its Form 10-Q and Form 10-K. The Company has until June 15, 2026, to submit a compliance plan, with Nasdaq discretion to grant up to 180 days from the Form 10-K due date to regain compliance.
View raw filing on EDGAR →Aperture AC consummated its IPO on May 22, 2026, raising $102 million through the sale of 10.2 million units at $10.00 per unit. The filing describes the Company's initial business combination structure and multiple definitive agreements (underwriting, trust, registration rights, sponsor placement, and administrative services agreements) entered into in connection with the SPAC formation.
View raw filing on EDGAR →Simultaneously with the IPO closing, Aperture AC completed a private placement of 311,000 units to the Sponsor and Underwriters at $10.00 per unit for $3.11 million, issued pursuant to Section 4(a)(2) exemption from registration.
View raw filing on EDGAR →Aperture AC appointed three individuals—Zhen Tan, Thomas Elliot Friend, and Song Pettus—to the audit committee and compensation committee effective May 20, 2026, with two serving as committee chairs.
View raw filing on EDGAR →Aperture AC amended its memorandum and articles of association in connection with the IPO, a material corporate governance event disclosed in the Registration Statement.
View raw filing on EDGAR →This is a completed disposition of a material asset—the Lakeway Resort and Spa in Austin, Texas—sold by Ashford Lakeway LP (an indirect wholly owned subsidiary of Ashford Hospitality Trust) for $37.75 million in cash. The filing explicitly states completion on May 19, 2026, under Item 2.01, which is the standard disclosure vehicle for asset dispositions. The sale price and nature of the asset (a resort property) are material to a hospitality REIT's portfolio and financial position.
View raw filing on EDGAR →